Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine
- 20 September 1999
- Vol. 17, S22-S27
- https://doi.org/10.1016/s0264-410x(99)00231-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Quinolone‐ResistantSalmonella typhiin Viet Nam: Molecular Basis of Resistance and Clinical Response to TreatmentClinical Infectious Diseases, 1997
- Short courses of ofloxacin for the treatment of enteric feverTransactions of the Royal Society of Tropical Medicine and Hygiene, 1997
- Impact of age and drug resistance on mortality in typhoid fever.Archives of Disease in Childhood, 1996
- Short Course of Ofloxacin for Treatment of Multidrug-Resistant TyphoidClinical Infectious Diseases, 1995
- Multidrug-resistant typhoid fever in childrenThe Pediatric Infectious Disease Journal, 1994
- Salmonella typhi infection in children younger than five years of ageThe Pediatric Infectious Disease Journal, 1993
- Multidrug-Resistant Typhoid in Children: Presentation and Clinical FeaturesClinical Infectious Diseases, 1991
- Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trialVaccine, 1990
- PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVERThe Lancet, 1987
- A SEVEN-YEAR FIELD TRIAL OF TWO TYPHOID VACCINES IN GUYANAThe Lancet, 1967